| Barbara E Salamon, MD | |
|
2604 Dr Martin Luther King Jr Blvd, New Bern, NC 28562-4238 | |
| (252) 638-4023 | |
| (252) 633-2833 |
| Full Name | Barbara E Salamon |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 42 Years |
| Location | 2604 Dr Martin Luther King Jr Blvd, New Bern, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982669594 | NPI | - | NPPES |
| 154P3 | Other | NC | BCBSNC |
| 5913166 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 2009-01710 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolina East Medical Center | New bern, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinaeast Physicians | 0143378117 | 180 |
News Archive
Democratic Gov. Terry McAuliffe was unsuccessful in his effort to get a divided legislature to agree to expand health coverage to thousands of poor state residents. Analysts watch to see if he will work to expand Medicaid on his own.
Regado Biosciences, Inc., a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the United States Food and Drug Administration has accepted the company's investigational new drug (IND) application for REG2. Regado previously completed a single escalating-dose Phase 1 clinical trial of REG2 and plans to conduct additional clinical testing in sub-acute venous thrombosis indications in the future.
Cancer Research funded scientists have discovered that a genetic marker can be used to identify relatives of bowel cancer patients who are much more likely to develop the disease than the general population.
Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.
› Verified 5 days ago
| Entity Name | Carolinaeast Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104066794 PECOS PAC ID: 0143378117 Enrollment ID: O20090430000303 |
News Archive
Democratic Gov. Terry McAuliffe was unsuccessful in his effort to get a divided legislature to agree to expand health coverage to thousands of poor state residents. Analysts watch to see if he will work to expand Medicaid on his own.
Regado Biosciences, Inc., a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the United States Food and Drug Administration has accepted the company's investigational new drug (IND) application for REG2. Regado previously completed a single escalating-dose Phase 1 clinical trial of REG2 and plans to conduct additional clinical testing in sub-acute venous thrombosis indications in the future.
Cancer Research funded scientists have discovered that a genetic marker can be used to identify relatives of bowel cancer patients who are much more likely to develop the disease than the general population.
Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barbara E Salamon, MD Po Box 896206, Charlotte, NC 28289-6206 Ph: (252) 638-4023 | Barbara E Salamon, MD 2604 Dr Martin Luther King Jr Blvd, New Bern, NC 28562-4238 Ph: (252) 638-4023 |
News Archive
Democratic Gov. Terry McAuliffe was unsuccessful in his effort to get a divided legislature to agree to expand health coverage to thousands of poor state residents. Analysts watch to see if he will work to expand Medicaid on his own.
Regado Biosciences, Inc., a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the United States Food and Drug Administration has accepted the company's investigational new drug (IND) application for REG2. Regado previously completed a single escalating-dose Phase 1 clinical trial of REG2 and plans to conduct additional clinical testing in sub-acute venous thrombosis indications in the future.
Cancer Research funded scientists have discovered that a genetic marker can be used to identify relatives of bowel cancer patients who are much more likely to develop the disease than the general population.
Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.
› Verified 5 days ago
Jenny Hyppolite, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2604 Dr Martin Luther King Jr Blvd, New Bern, NC 28562 Phone: 252-638-4023 Fax: 252-633-2833 | |
Dr. James L. Perruquet, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 702 Newman Rd, New Bern, NC 28562 Phone: 252-633-5333 Fax: 252-633-9443 | |
Dr. Deborah A. Milkowski, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 702 Newman Rd, New Bern, NC 28562 Phone: 252-633-1678 Fax: 252-633-9443 | |
Richard Forbes Gorman Jr., MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2000 Neuse Blvd, New Bern, NC 28560 Phone: 252-636-5135 Fax: 252-636-5395 | |
Craig Mathew Zavelo, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 670 Cardinal Place, New Bern, NC 28562 Phone: 252-636-6222 Fax: 252-636-5385 | |
Jennifer Aron, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2000 Neuse Blvd, New Bern, NC 28560 Phone: 252-633-8730 Fax: 252-633-8736 | |
Manuel Montero, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 970 Newman Rd, New Bern, NC 28562 Phone: 252-633-9262 Fax: 252-317-2094 |